# EDGAR Filing Document

**Accession Number:** 0001694426
**File Stem:** 0001628280-26-041875
**Filing Date:** 2026-6
**Character Count:** 31841
**Document Hash:** 5bae41ffd0f88bb704aee8f244eea9a7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-041875.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001628280-26-041875

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260609

**DATE AS OF CHANGE**: 20260609

**EFFECTIVENESS DATE**: 20260609

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Delek US Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001694426
- **STANDARD INDUSTRIAL CLASSIFICATION:** PETROLEUM REFINING [2911]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 352581557
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296636
- **FILM NUMBER:** 261075973

**BUSINESS ADDRESS:**
- **STREET 1:** 310 SEVEN SPRINGS WAY
- **STREET 2:** SUITE 500
- **CITY:** BRENTWOOD
- **STATE:** TN
- **ZIP:** 37027
- **BUSINESS PHONE:** 615-771-6701

**MAIL ADDRESS:**
- **STREET 1:** 310 SEVEN SPRINGS WAY
- **STREET 2:** SUITE 500
- **CITY:** BRENTWOOD
- **STATE:** TN
- **ZIP:** 37027

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Delek Holdco, Inc.
- **DATE OF NAME CHANGE:** 20170111

**As filed with the Securities and Exchange Commission on June 9, 20256**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

**DELEK US HOLDINGS, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **35-2581557** |
| (State of Incorporation) | (I.R.S. Employer Identification No.) |
| **310 Seven Springs Way,** | **37027** |
| **Suite 500** | **37027** |
| **Brentwood, Tennessee** | **37027** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**Delek US Holdings, Inc. 2026 Long-Term Incentive Plan**

(Full title of the plan)

**Denise McWatters**

**Executive Vice President, General Counsel <br>and Corporate Secretary** 

**Delek US Holdings, Inc.**

**310 Seven Springs Way, Suite 500**

**Brentwood, Tennessee 37027**

(Name and address of agent for service)

**(615) 771-6701**

(Telephone number, including area code, of agent for service)

*Copies to:*

**Stephen C. Hinton**

**Bradley Arant Boult Cummings LLP 1221 Broadway, Suite 2400**

**Nashville, Tennessee 37203**

**(615) 252-3585**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Large accelerated filer | ☑ | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Do not check if a smaller reporting company) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller reporting company | ☐ |
| | | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company | ☐ |

---

------

**<u>EXPLANATORY NOTE</u>**

This Registration Statement on Form S-8 ("Registration Statement") relates to shares of common stock, par value $0.01 per share ("Common Stock"), of Delek US Holdings, Inc., a Delaware corporation (the "Company"), that may be offered for sale to participants under the Delek US Holdings, Inc. 2026 Long-Term Incentive Plan, as amended from time to time (the "2026 Plan"). On April 20, 2026 (the "Effective Date"), the stockholders of the Company approved the 2026 Plan. Shares available for grant under the 2026 Plan consist of (i) 1,300,000 shares of Common Stock, (ii) 3,738,087 shares of Common Stock that remained available for grant under the Company's 2016 Long-Term Incentive Plan (the "Prior Plan") as of the Effective Date, and (iii) any shares of Common Stock subject to awards granted under the Prior Plan that are outstanding as of the Effective Date but that are forfeited, terminated, expire or lapse without being exercised (to the extent applicable), or that are settled for cash. This Registration Statement is being filed by the Company to register 5,038,087 shares of Common Stock issuable under the 2026 Plan.

------

**<u>PART I</u>**

**<u>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</u>**

**Item 1. Plan Information.**

The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants in the 2026 Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the "Securities Act"). Such documents are not being filed with the Securities and Exchange Commission (the "Commission") but constitute, along with the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Form S-8, a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**Item 2. Registrant Information and Employee Plan Annual Information.**

The Company will furnish without charge to each person to whom the prospectus is delivered, upon the written or oral request of such person, a copy of any and all of the documents incorporated by reference in Item 3 of Part II of this Registration Statement, other than exhibits to such documents (unless such exhibits are specifically incorporated by reference to the information that is incorporated) and any other documents required to be delivered pursuant to Rule 428(b) under the Securities Act. Those documents are incorporated by reference in the Section 10(a) prospectus. Requests should be directed to the Secretary of the Company at the address and telephone number on the cover of this Registration Statement.

------

**<u>PART II</u>**

**<u>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</u>**

**Item 3. Incorporation of Documents by Reference**

The following documents filed with the Commission by the Company pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the "1934 Act"), are incorporated herein by reference (other than portions of those documents furnished or otherwise not deemed to be filed):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 27, 2026 ("Annual Report");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026 filed with the SEC on April 29, 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• all other reports filed with the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act since December 31, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the disclosures set forth under the caption "Description of Delek Capital Stock" in the Company's Registration Statement on Form S-4 (File No. 333-222014), first filed with the SEC on December 13, 2017, as amended on January 4, 2018, and any other amendment or report filed for the purpose of updating such description, including the Description of Common Stock set forth in Exhibit 4.8 to the Annual Report.

In addition, any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this Registration Statement, which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with SEC rules shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference in or deemed to be part of this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement or in any subsequently filed document that also is or is deemed to be incorporated by reference in this Registration Statement modifies or supersedes that statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4. Description of Securities**

Not Applicable

**Item 5. Interests of Named Experts and Counsel**

Not Applicable.

**Item 6. Indemnification of Directors and Officers** 

Section 145 of the Delaware General Corporation Law (the "DGCL") permits a corporation, under specified circumstances, to indemnify its directors, officers, employees and agents against expenses (including attorneys' fees) and other liabilities actually and reasonably incurred by them as a result of any suit (other than a suit brought by or in the right of the corporation) brought against them in their capacity as such, if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, if they had no reasonable cause to believe their conduct was unlawful. Section 145 of the DGCL also provides that directors, officers, employees and agents may also be indemnified against expenses (including attorneys' fees) incurred by them in connection with a suit brought by or in the right of the corporation if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made, unless otherwise determined by the court, if such person was adjudged liable to the corporation.

The DGCL also provides that the indemnification described above will not be deemed exclusive of other indemnification that may be granted by a corporation pursuant to its by-laws, disinterested directors' vote, stockholders' vote, agreement or otherwise.

The DGCL also provides corporations with the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation in a similar capacity for another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against him or her in any such capacity, or arising out of his or her status, whether or not the corporation would have the power to indemnify him or her against such liability as described above.

The Company's Second Amended and Restated Certificate of Incorporation ("Certificate of Incorporation") provides that no director of the Company, and no officer of the Company serving in such capacity, shall be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director or officer to the fullest extent permissible under the DGCL or other Delaware law.

------

The Company's Fifth Amended and Restated Bylaws ("Bylaws") provide that, to the fullest extent not prohibited by the DGCL or any other applicable law, the Company shall indemnify its directors and executive officers; provided, however, that the Company may modify the extent of such indemnification by individual contracts with its directors and executive officers.

The above discussion of the DGCL and the Certificate of Incorporation and Bylaws is not intended to be exhaustive and is qualified in its entirety by such statutes, the Certificate of Incorporation and the Bylaws.

The Company has entered into indemnification agreements with each of the Company's directors and officers. These agreements provide that the Company will indemnify each of their directors officers to the fullest extent permitted by law and the Certificate of Incorporation and Bylaws.

The Company maintains liability insurance for the benefit of its directors and officers.

**Item 7. Exemption from Registration Claimed**

Not Applicable.

------

**Item 8. Exhibits**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |

---

&nbsp;&nbsp;&nbsp;&nbsp;<u>[5.1 \*](dk-ex51xbradleyconsentapri.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>[Opinion of Bradley Arant Boult Cummings LLP as to the validity of the securities being registered.](dk-ex51xbradleyconsentapri.htm)</u>

&nbsp;&nbsp;&nbsp;&nbsp;<u>[10.1](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)[\*](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>[Delek US Holdings, Inc. 2026 Long-Term Incentive Plan](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)[(incorporated by reference to Exhibit 10.1 to the](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)[Company's 8-K filed on April 2](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)[2](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)[, 2026).](https://www.sec.gov/Archives/edgar/data/1694426/000162828026026467/ex1012026longtermincentive.htm)</u>

&nbsp;&nbsp;&nbsp;&nbsp;<u>[23.1 \*](dk-ex231xeydraftconsentjun.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consent of Ernst & Young LLP, independent registered public accounting firm.](dk-ex231xeydraftconsentjun.htm)</u>

&nbsp;&nbsp;&nbsp;&nbsp;23.2 &nbsp;&nbsp;&nbsp;&nbsp;Consent of Counsel (included in Exhibit 5.1).

&nbsp;&nbsp;&nbsp;&nbsp;[24.1](#ibc2e049a9881408b8510c9b5bd17c04b_1)&nbsp;&nbsp;&nbsp;&nbsp;Power of Attorney (contained on the signature page hereto).

<u>[107 \*](exfilingfees.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>[Filing Fee Table](exfilingfees.htm)</u>

\* Filed herewith

**Item 9. Undertakings**

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

*provided, however*, *that*, paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered hereby which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Brentwood, State of Tennessee, on June 2, 2026.

DELEK US HOLDINGS, INC.

By: <u>/s/ Robert Wright</u>

Name: Robert Wright

Title: Executive Vice President and Deputy Chief Financial Officer&nbsp;&nbsp;&nbsp;&nbsp;

------

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Avigal Soreq and Robert Wright, and each of them, his or her true and lawful attorneys-in-fact and agents with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-8 with any completions, additions, deletions or other changes that either shall deem necessary, appropriate or advisable, to sign any or all amendments to this Registration Statement on Form S-8, including post-effective amendments, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, and hereby ratifies and confirms all his or her said attorneys-in-fact and agents, or any of them, or his or her substitute or substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Ezra Uzi Yemin | Chairman and Director | June 3, 2026 |
| Ezra Uzi Yemin |  |  |
| /s/ Avigal Soreq | President, Chief Executive Officer and Director | June 4, 2026 |
| Avigal Soreq | (Principal Executive Officer) |  |
| /s/ Mark Hobbs | Executive Vice President and Chief Financial Officer | June 9, 2026 |
| Mark Hobbs | (Principal Financial Officer) |  |
| /s/ Robert Wright | &nbsp;&nbsp;Executive Vice President and Deputy Chief Financial Officer | June 2, 2026 |
| Robert Wright | (Principal Accounting Officer) |  |
| /s/ Christine Benson Schwartzstien | Director | June 3, 2026 |
| Christine Benson Schwartzstein |  |  |
| /s/ William J. Finnerty | Director | June 4, 2026 |
| William J. Finnerty |  |  |
| /s/ Richard J. Marcogliese | Director | June 2, 2026 |
| Richard J. Marcogliese |  |  |
| /s/ Leonardo Moreno | Director | June 4, 2026 |
| Leonardo Moreno |  |  |
| /s/ Gary M. Sullivan, Jr. | Director | June 3, 2026 |
| Gary M. Sullivan, Jr. |  |  |
| /s/ Vicky Sutil | Director | June 3, 2026 |
| Vicky Sutil |  |  |
| /s/ Laurie Z. Tolson | Director | June 2, 2026 |
| Laurie Z. Tolson |  |  |
| /s/ Shlomo Zohar | Director | June 2, 2026 |
| Shlomo Zohar |  |  |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? exfilingfees

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-8**

(Form Type)

**Delek US Holdings, Inc.**

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Fee Calculation Rule** | **Amount Registered** <sup>(1)</sup> | **Proposed Maximum Offering Price Per Share** <sup>(2)</sup> | **Maximum Aggregate Offering Price** <sup>(2)</sup> | **Fee Rate** | **Amount of Registration Fee** <sup>(3)</sup> |
| Equity | Common Stock, par value $0.01 per share | Rule 457(c) and Rule 457(h) | 5038087 | $46.33 | $233414570.71 | $0.00013810 | $32234.55 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $233414570.71 |  | $32234.55 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  | $7834.69 |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $24399.86 |

---

<u>Table 2: Fee Offset Claims and Sources</u>

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Registrant or Filer Name** | **Form or Filing Type** | **File Number** | **Initial Filing Date** | **Filing Date** | **Fee Offset Claimed** | **Security Type Associated with Fee Offset Claimed** | **Security Title Associated with Fee Offset Claimed** | **Unsold Securities Associated with Fee Offset Claimed** | **Unsold Aggregate Offering Amount Associated with Fee Offset Claimed** | **Fee Paid with Fee Offset Source** |
| Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) |
| Fee Offset Claims | Delek US Holdings, Inc. | S-8 | 333-287040 | May 7, 2025 |  | $3828.11 | Equity | Common Stock, par value $0.01 per share | 1900000 | $25004000.00 |  |
| Fee Offset Claims | Delek US Holdings, Inc. | S-8 | 333-271784 | May 9, 2023 |  | $4006.58 | Equity | Common Stock, par value $0.01 per share | 1838087 | $36357360.86 |  |
| Fee Offset Sources | Delek US Holdings, Inc. | S-8 | 333-287040 |  | May 7, 2025 |  |  |  |  |  | $3828.11 |
| Fee Offset Sources | Delek US Holdings, Inc. | S-8 | 333-271784 |  | May 9, 2023 |  |  |  |  |  | $4006.58 |

---

------

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional securities that may be offered or issued pursuant to the Delek US Holdings, Inc. 2026 Long-Term Incentive Plan, as amended (the "2026 Plan") as a result of adjustments for stock dividends, stock splits or similar transactions effected without receipt of consideration, that increase the number of outstanding shares of the common stock, par value $0.01 per share (the "Common Stock") of Delek US Holdings, Inc. (the "Company").

(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act, based upon the average of the high and low sales prices of the Common Stock on the New York Stock Exchange on June 4, 2026.

(3) The Company previously registered (i) 1,900,000 shares of Common Stock pursuant to the Registration Statement on Form S-8 (File Number 333-287040) filed on May 7, 2025 and (ii) 2,015,000 shares of Common Stock pursuant to the Registration Statement on Form S-8 (File Number 333-271784) filed on May 9, 2023 (collectively, the "Prior Registration Statements"). Any offerings that included the unsold securities registered thereunder have been terminated. The Company expects to offset the registration fee due hereunder by an amount of fees that was previously paid with respect to the Prior Registration Statements pursuant to Rule 457(p) under the Securities Act. The fee previously paid for the Prior Registration Statements was $8,220.32. Pursuant to Rule 457(p) under the Securities Act, $7,834.69 of the previously paid fee remains available for fee offsets by the Registrant as of the date of this Registration Statement. Pursuant to Rule 457(p) under the Securities Act, the Registrant hereby offsets $7,834.69 of the registration fee due under this Registration Statement from the fees previously paid in connection with the Prior Registration Statements.

## Exhibit 5.1

**Exhibit 5.1**

![image_12.jpg](image_12.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 20, 2026

Delek US Holdings, Inc.

310 Seven Springs Way, Suite 500

Brentwood, Tennessee 37027

Ladies and Gentlemen:

We have acted as special counsel to Delek US Holdings, Inc., a Delaware corporation (the "***Company***"), in connection with the proposed issuance by the Company of up to 1,300,000 shares of the Company's common stock, par value $0.01 per share (the "***Shares***"), pursuant to the Delek US Holdings, Inc. 2026 Long-Term Incentive Plan (the "***2026 Plan***"). The Shares are included in the Company's Registration Statement on Form S-8 (the "***Registration Statement***"), filed by the Company with the U.S. Securities and Exchange Commission (the "***SEC***") under the provisions of the Securities Act of 1933, as amended (the "***Securities Act***"), on the date hereof. This opinion is being delivered to you in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act.

In connection with rendering the opinion set forth in this opinion letter, we have reviewed the Registration Statement, the 2026 Plan and the originals, or photostatic or certified copies, of such records of the Company and certificates of officers of the Company, certificates of public officials and such other documents as we have deemed relevant and necessary as a basis for the opinion expressed herein.

In our examination, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to all original documents of all documents submitted to us as copies and the accuracy and completeness of all information provided to us by the Company.

We have also assumed, without independent investigation, that at the time of the issuance of the Shares: (i) all of the terms and conditions for such issuance set forth in the 2026 Plan and any related agreements will have been fully satisfied, waived or discharged; (ii) each award agreement setting forth the terms of each award granted pursuant to the 2026 Plan will be consistent with the 2026 Plan and will have been duly authorized and validly executed and delivered by the parties thereto; (iii) a sufficient number of shares of Common Stock will remain available for issuance; and (iv) the legal consideration payable in connection with the issuance of the Shares pursuant to the 2026 Plan will not be less than the par value of the Common Stock and will be otherwise proper and sufficient.

Based upon the foregoing and the other matters stated herein, we are of the opinion that, when issued and delivered in accordance with the terms set forth in the 2026 Plan and against payment of the consideration therefor, the issuance of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable.

We render no opinion herein as to matters involving the laws of any jurisdiction other than the General Corporation Law of the State of Delaware, as amended (the "***DGCL***"), and the United States of America. This opinion is limited to the current DGCL and the current federal laws of the United States, and to the facts as they exist on the date hereof. We assume no obligation to revise or supplement our opinion should the present laws, or the interpretations thereof, be changed in respect of any circumstances or events that occur subsequent to the date hereof. This opinion letter is limited to the opinion expressly stated herein, and no other opinions are to be inferred or implied.

------

We hereby consent to the filing of this opinion with the SEC as an Exhibit to the above-referenced Registration Statement. In giving this consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the SEC promulgated thereunder.

Very truly yours,

/s/ Bradley Arant Boult Cummings, LLP

## Exhibit 23.1

**<u>Exhibit 23.1</u>**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2026 Long-Term Incentive Plan of Delek US Holdings, Inc. of our reports dated February 27, 2026, with respect to the consolidated financial statements of Delek US Holdings, Inc., and the effectiveness of internal control over financial reporting of Delek US Holdings, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; /s/ Ernst & Young LLP

Nashville, Tennessee<br>June 9, 2026

<br>